Literature DB >> 19800189

Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study.

Miguel Angel Campanero1, Manuel Escolar, Guiomar Perez, Emilio Garcia-Quetglas, Belen Sadaba, Jose Ramon Azanza.   

Abstract

Diosmetin (3',5,7-trihydroxy-4'-methoxyflavone) is the aglycone of the flavonoid glycoside diosmin (3',5,7-trihydroxy-4'-methoxyflavone-7-ramnoglucoside). Diosmin is hydrolyzed by enzymes of intestinal micro flora before absorption of its aglycone diosmetin. A specific, sensitive, precise, accurate and robust HPLC assay for the simultaneous determination of diosmin and diosmetin in human plasma was developed and validated. Plasma samples were incubated with beta-glucuronidase/sulphatase. The analytes were isolated by liquid-liquid extraction with tert-butyl methyl ether at pH 2, and separated on a C(18) reversed-phase column using a mixture of methanol/1% formic acid (58:42, v/v) at a flow rate of 0.5ml/min. APCI in the positive ion mode and multiple reaction monitoring (MRM) method was employed. The selected transitions for diosmin, diosmetin and the internal standard (7-ethoxycoumarin) at m/z were: 609.0-->463.0, 301.2-->286.1 and 191, respectively. A good linearity was found in the range of 0.25-500ng/ml (R(2)>0.992) for both compounds. The intra-batch assay precision (CV) for diosmin and diosmetin ranged from 1.5% to 11.2% and from 2.8% to 12.5%, respectively, and the inter-batch precision were from 5.2% to 11.5% and 8.5% to 9.8%, respectively. The accuracy was well within the acceptable range the accuracies (from -2.7% to 4.2% and -1.6% to 3.5% for diosmin and diosmetin, respectively). The mean recoveries of diosmin, diosmetin and the internal standard were 87.5%, 89.2% and 67.2%. Stability studies showed that diosmin and diosmetin were stable in different conditions. Finally, the method was successfully applied to the pharmacokinetic study of diosmin in healthy volunteers following a single oral administration (Daflon). Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800189     DOI: 10.1016/j.jpba.2009.09.012

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  19 in total

Review 1.  A review on pharmacological and analytical aspects of diosmetin: a concise report.

Authors:  Kanika Patel; Manoj Gadewar; Vijay Tahilyani; Dinesh Kumar Patel
Journal:  Chin J Integr Med       Date:  2013-10-04       Impact factor: 1.978

2.  Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration.

Authors:  Raffaele Serra; Raffaele Grande; Lucia Butrico; Gianluca Buffone; Francesco G Caliò; Aida Squillace; Barbara A Rizzo; Mafalda Massara; Francesco Spinelli; Alessia G Ferrarese; Giovanni de Caridi; Luca Gallelli; Stefano de Franciscis
Journal:  Int Wound J       Date:  2014-02-25       Impact factor: 3.315

3.  Diosmin protects rat retina from ischemia/reperfusion injury.

Authors:  Nianting Tong; Zhenzhen Zhang; Yuanyuan Gong; Lili Yin; Xingwei Wu
Journal:  J Ocul Pharmacol Ther       Date:  2012-04-17       Impact factor: 2.671

Review 4.  Pharmacology of Diosmin, a Citrus Flavone Glycoside: An Updated Review.

Authors:  Samar H Gerges; Sara A Wahdan; Doaa A Elsherbiny; Ebtehal El-Demerdash
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-10-23       Impact factor: 2.441

5.  Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes.

Authors:  Hendawy Om; Mehrez E El-Naggar; Mona El-Banna; Moustafa M G Fouda; Sarah I Othman; Ahmed A Allam; Osama M Morsy
Journal:  Invest New Drugs       Date:  2020-02-11       Impact factor: 3.850

6.  The effects of diosmin on aflatoxin-induced liver and kidney damage.

Authors:  Gökhan Eraslan; Zeynep Soyer Sarıca; Latife Çakır Bayram; Muhammet Yasin Tekeli; Murat Kanbur; Mürsel Karabacak
Journal:  Environ Sci Pollut Res Int       Date:  2017-10-08       Impact factor: 4.223

7.  Diosmin protects against ethanol-induced gastric injury in rats: novel anti-ulcer actions.

Authors:  Hany H Arab; Samir A Salama; Hany A Omar; El-Shaimaa A Arafa; Ibrahim A Maghrabi
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

8.  Synthesis, Spectral Characterization, and Biochemical Evaluation of Antidiabetic Properties of a New Zinc-Diosmin Complex Studied in High Fat Diet Fed-Low Dose Streptozotocin Induced Experimental Type 2 Diabetes in Rats.

Authors:  Veerasamy Gopalakrishnan; Subramanian Iyyam Pillai; Sorimuthu Pillai Subramanian
Journal:  Biochem Res Int       Date:  2015-12-09

Review 9.  Antidiabetic properties of dietary flavonoids: a cellular mechanism review.

Authors:  Ramachandran Vinayagam; Baojun Xu
Journal:  Nutr Metab (Lond)       Date:  2015-12-23       Impact factor: 4.169

10.  Confirmation of diosmetin 3-O-glucuronide as major metabolite of diosmin in humans, using micro-liquid-chromatography-mass spectrometry and ion mobility mass spectrometry.

Authors:  Luigi Silvestro; Isabela Tarcomnicu; Constanta Dulea; Nageswara Rao B N Attili; Valentin Ciuca; Dan Peru; Simona Rizea Savu
Journal:  Anal Bioanal Chem       Date:  2013-08-16       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.